Showing 1 - 10 of 44
Persistent link: https://www.econbiz.de/10003976943
Persistent link: https://www.econbiz.de/10012050900
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10014195216
Persistent link: https://www.econbiz.de/10008661786
Persistent link: https://www.econbiz.de/10003931919
Persistent link: https://www.econbiz.de/10003953402
Persistent link: https://www.econbiz.de/10009234175
Persistent link: https://www.econbiz.de/10009390015
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10009659550
Persistent link: https://www.econbiz.de/10009706123